The University of Alabama at Birmingham has received a $426,000 grant from the Alabama Department of Public Health to improv ...
Weight Loss and Substance Use. In addition to being a key feature of many eating disorders, body image disturbance and a ...
Los Angeles County Public Health Department officials say accidental drug overdose deaths are down for the third year in a ...
The Narcotics Control Commission (NACOC) and the UHAS Basic School (UBS) have called for sustained investment in youth empowerment, education and community engagement as critical tools in the fight ...
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself.
A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction. Review: The role of ...
LAUNCHING THE NATIONAL DRUG CONTROL STRATEGY: Today, President Trump’s Drug Czar Sara Carter released the National Drug Control Strategy. The Strategy is a road map for the United States to defeat the ...
The Trump administration is proposing wastewater testing on a national level to try to ferret out data on illegal drug use in real time, according to a draft of a new drug control strategy obtained by ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. New data shows major differences across the United States in drug use, ...
For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...
Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results